Telix Pharmaceuticals agrees to acquire RLS USA for upto $250 million
MELBOURNE: Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement to acquire RLS (USA) Inc., from its parent company, RLS Group Ltd. The acquisition significantly expands Telix’s North American manufacturing footprint and establishes the basis of a next generation radiometal…